Discover
NMRA
Neumora Therapeutics, Inc.
0.41
3 x 0.45
1 x 1.40
bid
ask
-
0.03
7.36%
12:36 PM
timesize
| Ytd | -77.37% | |
| 1y | -78.22% |
0.40
day range
0.43
0.40
52 week range
3.59
| Open | 0.43 | Prev Close | 0.44 | Low | 0.40 | High | 0.43 | Mkt Cap | 76.12M |
| Vol | 481.92K | Avg Vol | 1.19M | EPS | -1.23 | P/E | N/A | Forward P/E | -1.01 |
| Beta | 2.95 | Short Ratio | 4.59 | Inst. Own | 72.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.13 | 200-d Avg | 1.89 | 1yr Est | 11.77 |
| Income Statement | |||
| Operating Expenses | 42.19M | ||
| Research and Development Expense | 29.28M | ||
| Selling, General and Administrative Expense | 12.91M | ||
| Operating Income | -42.19M | ||
| Interest Expense | 1.82M | ||
| Net Income | -43.08M | ||
| Net Income Common Stock | -43.08M | ||
| Net Income Common Stock (USD) | -43.08M | ||
| Consolidated Income | -43.08M | ||
| Earnings per Basic Share | -0.23 | ||
| Earnings per Basic Share (USD) | -0.23 | ||
| Earnings per Diluted Share | -0.23 | ||
| Earning Before Interest & Taxes (EBIT) | -41.26M | ||
| Earning Before Interest & Taxes (USD) | -41.26M | ||
| Weighted Average Shares | 185.16M | ||
| Weighted Average Shares Diluted | 185.16M | ||
| Balance Sheet | |||
| Cash and Equivalents | 116.83M | ||
| Cash and Equivalents (USD) | 116.83M | ||
| Current Assets | 124.87M | ||
| Property, Plant & Equipment Net | 322.00K | ||
| Total Assets | 125.25M | ||
| Debt Current | 299.00K | ||
| Total Debt | 53.25M | ||
| Current Liabilities | 27.78M | ||
| Debt Non-Current | 52.95M | ||
| Total Liabilities | 80.73M | ||
| Accumulated Retained Earnings (Deficit) | -1.28B | ||
| Shareholders Equity | 44.52M | ||
| Shareholders Equity (USD) | 44.52M | ||
| Assets Non-Current | 375.00K | ||
| Total Debt (USD) | 53.25M | ||
| Liabilities Non-Current | 52.95M | ||
| Trade and Non-Trade Payables | 4.15M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 68.00K | ||
| Net Cash Flow from Financing | 9.29M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -30.24M | ||
| Issuance (Purchase) of Equity Shares | 9.74M | ||
| Issuance (Repayment) of Debt Securities | -445.00K | ||
| Net Cash Flow from Operations | -39.53M | ||
| Share Based Compensation | 7.18M | ||